Table 4.
Outcome- ICU length of stay in days.
| Outcome- ICU- length of stay | ||||
|---|---|---|---|---|
| Variables | Δβ | Lower CI | Upper CI | Pr(>|t|) |
| Group – non-IMV | Ref | Ref | Ref | Ref |
| IMV | 22.43 | 9.87 | 34.99 | <0.001 |
| Age | −0.19 | −0.7 | 0.32 | 0.47 |
| Gender – Male [Female = Reference] | −3.49 | −15.75 | 8.76 | 0.58 |
| BMI | −0.82 | −1.92 | 0.29 | 0.17 |
| CCI | 1.02 | −2.68 | 4.73 | 0.6 |
| ARB (Yes vs. No) | 16.63 | −3.04 | 36.31 | 0.12 |
| Remdesivir (Yes vs. No) | −2.86 | −14.97 | 9.25 | 0.65 |
| Hydroxychloroquine (Yes vs. No) | −7.91 | −33.16 | 17.33 | 0.55 |
| Tocilizumab (Yes vs. No) | 8.23 | −13.34 | 29.8 | 0.47 |
| Steroids (Yes vs. No) | 2.6 | −24.74 | 29.93 | 0.85 |
| Convalescent plasma | 81.12 | 49.95 | 112.29 | <0.001 |